Evidence map›Paper›PMID 31269094›Full record

ArticleRevista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)

Combined influence of illness duration and medication type on visual sensitivity in schizophrenia.

Natalia L Almeida, Thiago P Fernandes, Eveline H Lima, Hemerson F Sales, Natanael A Santos

Abstract read
In one paragraph

Article in Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Perceptual Functioning.Current topics in behavioral neurosciences · 2023
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natalia L AlmeidaLaboratório de Percepção, Neurociências e Comportamento (LPNeC), Universidade Federal da Paraíba (UFPB), João Pessoa, PB, Brazil.ORCID http://orcid.org/0000-0001-7131-7644
Thiago P FernandesLaboratório de Percepção, Neurociências e Comportamento (LPNeC), Universidade Federal da Paraíba (UFPB), João Pessoa, PB, Brazil.
Eveline H LimaLaboratório de Percepção, Neurociências e Comportamento (LPNeC), Universidade Federal da Paraíba (UFPB), João Pessoa, PB, Brazil.
Hemerson F SalesLaboratório de Percepção, Neurociências e Comportamento (LPNeC), Universidade Federal da Paraíba (UFPB), João Pessoa, PB, Brazil.
Natanael A SantosLaboratório de Percepção, Neurociências e Comportamento (LPNeC), Universidade Federal da Paraíba (UFPB), João Pessoa, PB, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePatients with schizophrenia have visual processing impairments. The main findings from the literature indicate that these deficits may be related to differences in paradigms, medications, and illness duration. This study is part of a large-scale study investigating visual sensitivity in schizophrenia. Here we aimed to investigate the combined effects of illness duration and antipsychotic use on contrast sensitivity function.

methodsData were collected from 50 healthy controls and 50 outpatients with schizophrenia (classified according to illness duration and medication type) aged 20-45 years old. The contrast sensitivity function was measured for spatial frequencies ranging from 0.2 to 20 cycles per degree using linear sine-wave gratings.

resultsPatients with an illness duration > 5 years had more pronounced deficits. Differences in the combined effects of illness duration and antipsychotic use were marked in patients on typical antipsychotics who had been ill > 10 years. No significant differences were found between typical and atypical antipsychotics in patients with an illness duration < 5 years.

conclusionVisual impairment was related to both long illness duration and medication type. These results should be tested in further studies to investigate pharmacological mechanisms.

Indexed as

AdultAntipsychotic AgentsCase-Control StudiesChlorpromazineContrast SensitivityFemaleHumansMaleMiddle AgedPsychiatric Status Rating ScalesSchizophreniaTime FactorsTreatment OutcomeVision DisordersVision, OcularYoung AdultAntipsychotic AgentsChlorpromazine

Identifiers

PMID31269094
PMCPMC6986493

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.